Subscribe To
GRTX / Galera Therapeutics: A Possible Solution To Severe Oral Mucositis In Head And Neck Cancer Patients
GRTX News
By Zacks Investment Research
August 14, 2023
3 Biotech Stocks Poised to Beat Q2 Earnings Estimates
We look at a few biotech companies, LEGN, KOD, GRTX, which are poised to beat second-quarter earnings estimates. more_horizontal
By Proactive Investors
August 10, 2023
Galera Therapeutics shares plummet after FDA rejects drug for cancer treatment side effect
Galera Therapeutics shares plunged by almost 85% after the clinical-stage biopharmaceutical company revealed its New Drug Application for its investig more_horizontal
By InvestorPlace
August 10, 2023
Why Is Galera Therapeutics (GRTX) Stock Down 83% Today?
Galera Therapeutics (NASDAQ: GRTX ) stock is falling hard on Thursday following a drug rejection by the FDA! In a Complete Response Letter ( CRL ), t more_horizontal
By Reuters
August 9, 2023
Galera shares tank after US FDA declines to approve inflammation disease drug
Galera Therapeutics Inc said the U.S. health regulator declined to approve its drug to treat radiotherapy-induced severe mouth inflammation in patient more_horizontal
By Seeking Alpha
April 24, 2023
Galera Therapeutics: A Possible Solution To Severe Oral Mucositis In Head And Neck Cancer Patients
Galera Therapeutics: A Possible Solution To Severe Oral Mucositis In Head And Neck Cancer Patients. more_horizontal
By 24/7 Wall Street
February 21, 2023
Piper Sandler Initiates Coverage of Galera Therapeutics With Overweight Recommendation
On February 21, 2023, Piper Sandler initiated coverage of Galera Therapeutics with a Overweight recommendation. more_horizontal
By Seeking Alpha
March 23, 2022
Is Galera Therapeutics Stock A Buy, Sell, Or Hold? Several Catalysts To Watch In 2022
Galera Therapeutics is developing drugs that reduce side effects from anti-cancer radiotherapy and improve the treatment outcome. more_horizontal
By Pulse2
December 20, 2021
Galera Therapeutics Stock (GRTX): Why The Price Surged Today
The stock price of Galera Therapeutics Inc (NASDAQ: GRTX) increased by 28.04% today. This is why it happened. more_horizontal